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Background: Investigation to identify factors that determine the clinical outcome of malaria are essential for the 
improvement of patient care in severe malaria cases.  
Objectives: To assess the parasitologic and haemato-immunological characteristics of malaria patients with and 
without HIV co-infection.  
Methods: Immune cells were enumerated using the Flow cytometer method. Haematological values were determined 
using the Coulter Counter system. Malaria parasite detection was conducted using standard microscopy; and HIV 
testing was conducted using Determine, ELISA and Western blot methods.  
Results: A total of 253 study participants, out of which 87 were control cases, and 166 were acute malaria patients 
(49.4% due to P. falciparum, 48.8 % due to P. vivax, 1.8% due to mixed infection) were included. Eight out of 166 
(4.8%) of the malaria patients were found to be HIV positive. Asexual stage parasitemia was increased in HIV positive 
falciparum patients (P=0.031). However, the increase in parasitemia in HIV positive vivax malaria patients was not 
significant. HIV infection is seen to aggravate the decrease in Haemoglobin (Hgb), Haematocrit (Hct) and Platelet (Plt) 
levels. Lymphopenia, CD4+ lymphocytopenia, eosinopenia, monocytosis and thrombocytopenia were found to be 
higher in both malaria infections compared to the control ones (P<0.05).  
Conclusion: Care should be taken when using immune cell counts for research or diagnostic purposes in malaria 
patients. The effects of HIV on parasitologic and haematologic values should be taken into account during the 
provision of care to HIV positive malaria patients. [Ethiop.J.Health Dev. 2005;19(2):132-139] 
 
Introduction 
One hundred fifty million malaria related deaths, of 
which 90% occur in sub-Saharan Africa, were estimated 
to have occurred over the whole of the 20
th 
century (1). 
Due to drug and insecticide resistance, malaria control is 
becoming more difficult (2).  Out of the 39.4 million 
people living with HIV worldwide, 64.5 % are found in 
sub Saharan Africa (3). In Ethiopia, while 66% of the 
population is at risk of malaria (4), 1.5 million people are 
infected with HIV (3). 
 
Due to the overlapping distribution of HIV and malaria, 
there is a theoretical possibility of concomitant infection, 
and the potential for immunological interactions between 
these two infections. However, there is inconsistency in 
the findings. Earlier studies done in Zaire (5), Burundi 
(6) and Zimbabwe (7) showed no interaction between 
these two infections. However, others have shown that P. 
falciparum antigens induced HIV-1 replication in vitro 
(8) and in vivo (9). HIV-1 infection was also found to 
reduce the immunity of pregnant women (10, 11) and 
increase the onset of malaria fever (12) in falciparum 
malaria cases.   
 
Malaria and HIV are known to be the most severe of all 
infections in Ethiopia, but no study has yet been done 
which evaluates the association between malaria and 
HIV, and the clinical outcome of malaria is also not 
universal, but it is dependent on local factors such as host 
genetics (13), parasite stages and strains (14) and levels 
of endemicity (15).  
 
This study was aimed at assessing the parasitological and 
haematologic features of acute falciparum and vivax 
malaria cases, and the effect of HIV infection on these 
parameters. Abnormalities such as fever (axillary 
temperature >=37.5
 0
C), leucopoenia (WBC <4000/µl), 
lymphopenia (lymphocytes <1400/µl), CD4+ lympho-
penia (CD4+ <300/µl), monocytosis (monocytes >800/ 
µl), monocytopenia (monocytes <200/µl), eosinopenia 
(eosinophils < 40/µl), neutophilia (neutrophil > 2500/µl), 
anaemia (Hgb < 12g/dl) and thrombocytopenia (Platelets 
< 150000/µl) (16,17) were also evaluated in HIV 
negative malaria patients in relation to healthy donors. 
 
Methods 
This cross sectional study was undertaken from 
November 2002 to November 2003 at Wonji Sugar 
Estate, 114 km away from Addis Ababa. The average 
elevation of the study area is 1500 masl and its climate is 
characteristic of tropical lowlands. Total annual rainfall 
is around 8324 mms and 65 % of the total falls occur 
within the months of June to September. The topography 
and climatic conditions of the area create suitable 
conditions for malaria transmission (18). 
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As the malaria epidemic during the study period was very 
low due to intensive malaria control activities. The 
researches in this study recruited all adults of both sexes 
(age > 15 years) infected with either P. falciparum or P. 
vivax malaria that and who came to attend Wonji 
Hospital from November 2002 – November 2003. 
Informed written consent was obtained from all the 
participants. All malaria cases were treated according to 
the national standard drug regimens. Clinical and 
demographic data were recorded using a standard 
questionnaire. Age and sex proportions matched that for 
HIV negative and HIV positive cases but aparasitemic 
adult volunteers were included as controls from the same 
area. 
 
The study was undertaken under the auspices of the 
Ethio-Netherlands AIDS Research Project (ENARP). It 
was ethically approved, nationally by the National 
Ethical Clearance Committee, NECC and institutionally 
by the Ethiopian Health and Nutrition Research Institute, 
EHNRI. 
 
About 6–8 ml of venous blood was collected from each 
study subject by venepuncture into Ethylenediamine tetra 
acetate (EDTA) tubes. Whole blood samples, slide 
smears and filled questionnaires were sent daily to the 
ENARP laboratory at Addis Ababa. 
 
Thick and thin blood films stained with 3% Giemsa were 
examined microscopically. At least 200 microscopic 
fields were scanned before labeling a smear as negative 
(19). Parasite number was counted against a 300 WBC 
count. Parasite density per micro litre of blood was 
calculated by multiplying the parasites counted by 
WBC/300 (19). 
 
Absolute counts of WBC and levels of haemoglobin, 
platelets and haematocrits were obtained by using the 
Coulter counter T540 method (Coulter Electronics, 
Florida, USA). 
 
HIV testing was conducted using Determine (Abbott 
Laboratories, Japan) rapid HIV1/2 test, Enzyme Linked 
Immunosorbant Assay (ELISA) (Vironostika-HIV Uni-
Form II, Organon Teknika, the Netherlands) and Western 
Blot (WB) (Gee labs Diagnostics, Singapore) as 
screening, confirmatory and tiebreaker methods 
respectively.   
 
Ten µl of the monoclonal antibodies, specific to the 
lymphocyte subsets (CD4+, CD8+, B and NK), were 
mixed with 50µl of whole blood sample in a test tube and 
mixed by the vortexing method. This was followed by 
incubation of the samples for 15 minutes in the dark, and 
at room temperature. To lyse the red blood cells, 450µl of 
fluorescent activated cell sorter (FACS) lysing solution 
(Becton Dickinson, San Jose, CA) was added. After 
vortexing, it was incubated for another 15 minutes at 
room temperature. This was followed by a three-color 
flow cytometry analysis done using the FACScan flow 
cytometer (Becton Dicknson, San Tase, CA), to enume-
rate the lymphocyte subsets.  
 
Statistical analyses were performed by using STATA 
version 7.0 and SPSS version 10.0 soft ware. Results 
were compared between groups that use parametric or 
non-parametric statistical tools where appropriate. The 
degree of correlation between variables was evaluated by 
using the Spearman correlation analysis method. For all 
the statistical tests, a two-tailed P-value of < 0.05 was 
considered significant. For the purpose of this study, 
seasons were classified as rainy (June-August), post rainy 
(September-October) and dry (November-May). 
  
Results 
Demographic data, WBC and CD4+ cell counts of the 
study participants are summarized in Tables 1 & 2. A 
total of 253 adults of both sexes were included in the 
study. Out of these, 87 aparasitemic individuals (46 
healthy and 41 HIV positive) were controls. The 
remaining 166 subjects (68.1% males) were malaria 
patients, of whom 82 (49.4 %) were falciparum, 81 (48.8 
%) vivax malaria patients, and 3 (1.8 %) had mixed 
infection. Eight (4.8 %) of the malaria patients (3 
falciparum and 5 vivax patients) were HIV-1 positives. 
There was no significant difference in the body 
temperature between falciparum and vivax malaria 
patients. However, it was higher in HIV co-infected 
falciparum than vivax patients (P = 0.034). 
 
Parasitological results 
Although no significant difference was detected in the 
proportions of falciparum and vivax malaria cases during 
the study period, there was a marked seasonal variation 
between the two parasites (P < 0.0001) as well as within 
the onset of falciparum (P< 0.0001) and vivax (P < 
0.0001) infections. The emergence of both parasites was 
considerably related with rainfall (Fig. 1). In the dry 
months (January-May), almost all malaria infections 
were due to P. vivax. When rainfall started in March, an 
immediate onset of falciparum malaria was observed in 
the two months, up to June. The onset both falciparum 
and vivax malaria then increased up to the month of 
August, parallel with the increase in rainfall. However, 
when the rainfall gets maximum in July and August, an 
immediate decrease in both parasites occurred. An 
immediate increase of both parasites was observed from 
October to December, following the decrease in rainfall 
in September. 
 
Monthly frequency of asexual and sexual parasite stages  
During P. falciparum infection, gametocyte stages started 
appearing in July, after about a month following the 
appearance of trophozoites, which occurred in June. 
However, gametocytes of P. vivax were observed 
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Table 1:  Characteristics of HIV negative falciparum (pf) and vivax (Pv) malaria patients and HIV negative 




) and CD4+ counts (per µl of blood) in Wonji Sugar 
Estate, November 2002-2003. 













Age (yrs) 36.2 ± 8.7 31.2 ± 9.1 29.3 ± 5.5 34.3 ± 5.7 0.152 0.042 
Sex; Male (%)  61(77.2%) 43 (56.7 %) 3 (100 %) 39 (84.7%)  0.319 0.001 
T (
0
C) 38.1± 0.8 37.9 ± 0.65 39.0 ±0.45 NA   
WBC (x10
3
) 4.8  ±1.7
†
 5.5 ±2.0 6.3±1.8 5.7 ±1.8 0.015 0.957 
CD4+ (per µl) 387 ±206 455 ±240 113±106 691±234 <0.0001 <0.0001 
a = P value when pf compared with control;     b= P value when pv compared with control 
† = Difference in WBC between pf and pv malaria patients (P = 0.031), using students t test 
T (
0




Table 2: Characteristics of HIV positive falciparum (pf) and vivax (pv) malaria patients and HIV negative 




) and CD4+ counts (per µl of blood) in Wonji Sugar 
Estate, November 2002-2003.  
  Study participants  P value   
Pf +HIV(n=3) Pv+HIV (n=5) Controls (HIV+) (n=41) a b 





 37.9 ±0.4 NA   
WBC (x10
3
) 2.0±0.91 4.5±2.3 5.4±1.4 0.0001 0.152 
CD4+ 78.6±20.9 225.2±116.5 274.0±196 0.023 0.929 
a = P value when pf +HIV compared with control;   b= P value when pv+HIV compared with control 























Figure 1:  Monthly distribution of P. falciparum and P. vivax  infections in relation to rainfall (per mm) (Rain fall 
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the increase in rainfall and the frequency of trophozoite 
stages. 
 
Asexual and sexual stage parasitic densities with and 
without HIV co-infection 
The mean trophozoite density of P. falciparum was found 
to be higher than that of P. vivax (P=0.0006). But, the 
reverse was true in gametocyte density (P< 0.0001). A 
significant increase in trophozoite density was observed 
in HIV positive falciparum patients (P=0.031). However, 
the increase in trophozoite and gametocyte densities in 
HIV positive vivax malaria patients was not significant 
(Table 3). Positive correlation was observed between 
trophozoite and gametocyte density in both P. vivax and 
P. falciparum infections, but this was significant only in 
vivax malaria patients (r= 0.33; P= 0.023; n=77). 
 
Table 3:  Mean and standard deviation (in parenthesis) of trophozoite and gametocyte 
densities (log10density/µl) of P. falciparum (pf) and P. vivax (pv) with and without HIV  
co-infection in Wonji Sugar Estate, November 2002-2003 
Malaria patients 
Trophozoite densities Gametocyte densities 
Pf (n=79) 3.9  (± 0.63) ** 1.7 (± 0.49) 
Pf + HIV (n=3) 4.9 (± 0.49) ● 0 
Pv (n= 76) 3.3 (± 0.62) 2.1 (± 0.53) 
††
 
PV + HIV (n= 5) 3.6(± 0.34) 2.1 (± 0.77) 
** P = 0.0006, variation in trophozoite density between pf and pv; using Student t test 
†† P < 0.0001, variation in gametocyte density between pf and pv; using Student t test 
● P = 0.031 when trophozoites of pf compared with pf + HIV, using Wilcoxon rank-sum test 
pf+HIV= HIV positive falciparum patients; Pv+HIV= HIV positive vivax malaria patients 
n= number of subjects 
 
Fever was positively correlated with trophozoite densities 
during P. falciparum malaria infection (r= 0.40; 
P=0.0003; n=79). The same result was also found during 
P. vivax infection, although this, too, is not significant.  
 
Haematological results 
Hgb, Hct and Plt values decreased in falciparum (P= 
0.001, P< 0.0001, P< 0.0001) and vivax (P = 0.0003, P = 
0.0002, P < 0.0001) malaria patients (Figure 2). 
However, no significant variation was found in any of the 
haematological values between the two malaria groups. 
No significant correlation was also observed between the 
decrease in all the haematologiacl values and the density 
of trophozoites or gametocytes of either P. falciparum or 
P. vivax. No seasonal difference of haematological values 
was also found within falciparum or within vivax malaria 
cases, as well as between the two malaria groups. 
 
HIV infection was seen to aggravate the decrease in the 
haematological levels of all the malaria patients, but this 
was significant only in the decrease of platelet levels in 
falciparum patients (P = 0.049). 
 
Haemato-immunological laboratory abnormalities Leuco-
poenia cases were higher only during P. falciparum 
(P=0.029), but lymphopenia and CD4+ lymphocytopenia  
cases  were  higher  in both falciparum 
 
 
(P<0.001, P<0.001) and vivax (P<0.001, P=0.001) 
malaria patients. Comparing the two patient groups, 
leucopoenia was higher in falciparum than in vivax 
patients (P=0.032), but no significant difference was 
observed in lymphopenia and CD4+  lymphocytopenia 
cases (Table 4). 
 
Monocytosis was also higher in both falciparum 
(P=0.026) and vivax (P=0.003) malaria patients, but an 
increase in monocytopenia was observed only during P. 
vivax infection (P= 0.015). No significant difference was 
found between the two malaria groups. 
 
Considering the granulocyte subsets, eosinopenia 
increased in both falciparum (P<0.001) and vivax 
(P=0.001) malaria patients, but the increase in 
neutrophilia and neutropenia cases in both malaria types 
was not significant. Neutrophilia on the other hand, was, 
found to be higher in vivax than in falciparum patients 
(P=0.026). 
 
In the case of Haematological abnormalities, 
thrombocytopenia was found to be higher in falciparum 
(P< 0.001) and vivax (P<0.001) malaria patients, but the 
increase in the proportion of anaemic cases in the two 
malaria groups was not significant. No difference was 
observed in thrombocytopenia, anaemia and febrile cases 
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Figure 2:  Mean values of haemoglobin, platelets and haematocrits in health controls (control), HIV positive but 
malaria negative controls (HIV+), HIV negative falciparum (pf) and vivax (pv) malaria patients, and in HIV 
positive falciparum (pf+HIV) and HIV positive vivax (pv+HIV) malaria patients in Wonji Sugar Estate, November 
2002-2003. 
 
Table 4:  Numbers and proportions (in parenthesis) of haemato-immunological laboratory abnormalities in 
acute falciparum (pf) and vivax (pv) malaria patients and health donors. Cut of values of laboratory 
abnormalities are in parenthesis in Wonji Sugar Estate, November 2002-2003. 
Laboratory abnormalities (cut off values) pf (n= 79) pv (n= 77) Controls (n= 46) 




12 (15.6) 6 (13.0) 




 12 (26.1) 




 2 (4.3) 
Monocytopenia (monocytes < 200/µl)  5 (6.3) 9 (11.4)
*
 0 





Neutrophilia (neutrophil > 2500/µl) 38 (48.1) 51 (65.8)
†
 26 (56.5) 
Neutropenia (neutrophil <2000/µl) 20  (25.3) 12 (15.8) 11 (23.9) 









 10 (21.7) 
Anaemia (Haemoglobin < 12g/dl)  15 (19.0) 8 (10.5) 3 (6.5) 
Febrile (Temperature > = 37.5 
0
C) 62 (78.5) 60 (77.6) NA 
** = P<0.01, * = 0.01 < P < 0.05 when pf or pv compared with controls, using chi-square test 
†= P < 0.05 when pf compared with pv, using chi-square test 
NA= not available 
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Discussion 
The overall yearly prevalence- 49.4 % of P. falciparum 
and 48.8% of P. vivax infection- as well as the seasonal 
variation between these two malaria species observed in 
this study was relatively similar to a previous study done 
in Nazareth  town (20). 
 
As relapsing is mainly a characteristic of the P. vivax 
species (21), almost all malaria cases occuring in the dry 
season (January - May) are expected to be due to P. vivax 
infection. The increase of both malaria species in the 
rainy (June-August) and post-rainy (September –
November) seasons could be related to the emergence 
and increase in number of  the female vector- Anopheles 
mosquito (22), where biting rates and the rate of 
transmission of malaria parasites are expected to increase 
(23). The observation of asexual stages of P. falciparum 
and P. vivax parasites in the blood film in June, while 
rainfall that starts in March could indicate the range of 
time the mosquito vector needs to complete its life cycle 
(22), plus the range of time between the first inoculation 
of malaria parasites (sporozoite) into the host and the first 
onset of the symptoms (21).  
 
As is the case with the previous report (14, 24), HIV 
infection was found to cause an increase in asexual stage 
density in falciparum malaria patients (P = 0.031), and 
also aggravated the decrease in Hgb, Hct and Plt levels in 
both malaria infections. Bone marrow infection 
gastrointestinal bleeding and soluble factors in the serum 
which affect haematopoiesis are some of the mechanisms 
by which the virus affects Hgb and Plt values (25).  
 
In agreement with the findings of this study other studies 
have reported a decrease in Hgb and Plt values (21) 
occurring during infection with the major species of 
malaria. The mechanical destruction of parasitized red 
blood cells, reduced RBC production in the bone 
marrow, phagocytosis of uninfected red blood cells and 
autoimmune destruction of RBCs are some of the 
mechanisms known to cause anaemia during malaria 
(21). On the other hand, the decrease in Plt counts is 
related to the activation of Plt by the chemical adenosine 
diphosphate (ADP) under which Plts will have a shorter 
life span (26). One of the reasons believed to explain the 
absence of significant correlation between the decrease in 
haematological values and the trophozoite density in this 
study could be phagocytosis of uninfected RBCs by 
macrophages (21).  
 
One of the reasons for the insignificant variation 
observed in the proportion of anaemia in falciparum and 
vivax malaria patients is the high proinflammatory to 
anti-inflammatory cytokines ratio that causes anaemic 
conditions (27). It could also be due to the short range of 
time existing between the onest of acute malaria 
symptoms and the time during which whole blood 
sample were taken from the patients for haematological 
analysis, so that most of the RBC are not haemolysed by 
the parasites. 
  
Although Meek et al (1) reported leucopoenia in vivax 
malaria patients, this was observed only in falciparum 
patients in the present study. The decrease in total 
lymphocyte counts (as observed in this study) could be 
one of the reasons for the occurrence of leucopoenia. 
Similar to the current study, lymphopenia has also been 
reported in falciparum patients from other geographic 
locations (28). Depletion in the lymphocyte subsets 
through apoptosis (29) or due to sequestration of the cells 
in the lymph nodes or other body tissues (30) are some of 
the reasons behind the occurrence of lymphopoenia in 
malaria patients. 
 
Consistent with the findings of this study, an increase in 
monocytes and neutrophil counts (31)) and a decrease in 
eaosinophil counts (32)) have been reported by others 
studies. Although the decrease in the number of 
eosinophils could be due to migration, sequestration or 
destruction of the cells (17, 33), the increase or decrease 
in the monocyte and granulocyte subsets during acute 
infection is basically determined by factors such as the 
rate of input of the cells from bone marrow to the blood 
circulation; the proportion of circulating cells to cells 
attached on endothelial cells; and the rate at which the 
cells are leaving from the blood to the body tissue (17).  
 
This study showed no significant difference in the 
proportion of P. falciparum and P. vivax infections over 
the study period. However, seasons have significant 
influence in the onset of both falciparum and vivax 
malaria. HIV co-infection seems to be associated with an 
increase in asexual stage parasite density in both P. vivax 
and P. falciparum infections. Both P. falciparum and P. 
vivax infections were associated with disrupted total 
WBC, lymphocyte and granulocyte subsets and 
monocyte counts, but in different ways. Both malaria 
species caused a decrease in haemoglobin, haematocrit 
and platelet levels. However, there was no significant 
correlation between the trophozoite and gametocyte 
densities of P. falciparum or P. vivax and the decreasing 
haematological values. HIV infection aggravated the 
decrease in haemoglobin, haematocrit and platelet levels 
in infections with both malaria species.  
 
The impact of HIV infection on the decrease in 
haematological levels and the increase of asexual parasite 
densities should be considered during the management of 
malaria patients co-infected with HIV.  For a better 
understanding of the existence of possible malaria–HIV 
interaction, however, a longitudinal study on a larger 
sample of participants is required. Disorders in WBC, 
lymphocyte, granulocyte and monocyte counts during 
acute malaria infections should also be accounted when 
enumerating these cells for diagnostic or research 
purposes, as optimal number of cells can not be found in 
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the peripheral blood. The impact of distortions in the 
normal profile of lymphocyte, monocyte and granulocyte 
cells due to acute malaria infections on: a) the clinical 
outcome (severity) of malaria and b) increasing 
susceptibility of the host to be co-infected by other new 
infectious agents must be further investigated. As these 
immune cells could be important (effector) cells that 
could fight infectious organisms. 
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